Transdermal penetration enhancers: applications, limitations, and potential.
about
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trialsIn vitro skin diffusion study of pure forskolin versus a forskolin-containing Plectranthus barbatus root extractIn vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.Discovery of transdermal penetration enhancers by high-throughput screening.Use of Kv1.3 blockers for inflammatory skin conditions.Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetrationVirtual design of chemical penetration enhancers for transdermal drug delivery.2940-nm Er:YAG fractional laser enhanced the effect of topical drug for psoriasis.Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical EvaluationIn vitro and in vivo percutaneous absorption of seleno-L-methionine, an antioxidant agent, and other selenium species.Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.Polymer-drug conjugates: recent progress on administration routes.Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects.Scaffolding proteins in the development and maintenance of the epidermal permeability barrier.Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model.Local Application of Statins Significantly Reduced Hypertrophic Scarring in a Rabbit Ear Model.The effects of equine skin preparation on transdermal drug penetration in vitro.Percutaneous absorption of salicylic Acid after administration of trolamine salicylate cream in rats with transcutol(®) and eucalyptus oil pre-treated skin.Development and Evaluation of Topical Gabapentin Formulations.Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization.Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship.Structure activity relationships in alkylammonium C12-gemini surfactants used as dermal permeation enhancers.Topical anti-inflammatory effects of isorhamnetin glycosides isolated from Opuntia ficus-indica.Ketoprofen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vivo and in vitro evaluations.Effect of solute lipophilicity on penetration through canine skin.Effects of active sunscreen ingredient combinations on the topical penetration of the herbicide 2,4-dichlorophenoxyacetic acid.Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis.Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.Penetration enhancing effects of selected natural oils utilized in topical dosage forms.Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis.Transdermal delivery of the potent analgesic dihydroetorphine: kinetic analysis of skin permeation and analgesic effect in the hairless rat.Heat: A Highly Efficient Skin Enhancer for Transdermal Drug Delivery.Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.Non-invasive Oil-Based Method to Increase Topical Delivery of Nucleic Acids to Skin.Nanoscale polymeric penetration enhancers in topical drug delivery
P2860
Q26745783-C73BA98E-F3BE-41E2-96FE-BEFAAFA0EE47Q28820879-9EFED585-F188-4849-83FC-C93233331DC3Q33985972-C7282B73-2AFF-488D-954A-E7B13318FA3EQ34287633-5F8F3B60-1150-47AA-9E5D-B9B7B6970F6FQ35915882-0F595C53-001F-4FCD-9E99-353AD58F0233Q36084040-45B98C89-665D-4DAA-93D1-DEB3D5D0A58AQ36307726-E18E04E5-B660-48F1-918A-4C09B7013215Q36413794-20877801-E3D5-436C-81E8-7B4613532843Q37049449-BB65210C-6275-4A15-888F-D5230FF09E8FQ37729812-7B70AAEB-17AD-4B58-B981-110BB2B30773Q38114136-46B6662B-23DC-4ECB-ADF9-600F9D59708EQ38206549-4957EA08-F2DF-4B8B-8ECF-80D25109EE3EQ38303433-263B6FE9-500F-4D18-87FE-D9EF676691B7Q39407147-ED2A5BA0-ED01-4244-BE10-42A46561D80BQ39547251-BD628975-FD12-451E-87D1-9FA15A90FF6EQ40984955-A77B4DCC-70D6-465C-8CCE-26C051EEFF9DQ41995825-9A2B84CE-F7A1-459F-B1A9-7A693EABA125Q42080183-C968F423-C9F3-4871-A88F-66BD6541DC44Q42366834-D451E111-9151-4B02-B810-B1CBAFC2E21BQ42581355-B1ABF39B-1705-4B40-BC48-D16B15622902Q42737276-7F66F31C-3D75-4777-9D2F-D120E3BB4687Q42962571-2060713B-7F97-4D97-8522-B907C59686DDQ43190969-F057AC8B-4738-4F3D-AD8A-BDBE805B5220Q44369334-CD7FC096-E86F-4E7D-878E-6D2A0366FDC8Q44840889-CFDAFDAE-1CE7-4AB1-BB73-B113F7A96D34Q45088865-6151FED2-A8F6-4C93-853D-03CB356DD146Q46389127-FCDDE5E6-F641-4ECB-A43A-5DCBFA654B82Q46579883-3ED8DDB0-7544-4049-8469-55EE80D6EBA2Q46670581-E48E834E-8C05-4C54-A697-726840BDAE75Q46719954-AF6C6F74-4C32-46AE-925B-8CC507F0F78EQ47935813-EE53C22E-4EB9-4A55-AE19-9C6754E5566AQ48986746-1CAABEE9-EA3C-473B-BDA2-2EA3FA3ACD67Q52677954-FAA981AF-E52C-4F5A-A5A4-B75CC00D14F9Q54936269-119470B6-20C2-49F4-9815-05E609512C80Q55077860-936BB111-2B23-450F-9271-C1ED5EC907BBQ57364719-B6BB9B18-A653-4986-8CE9-4111FBCEB5B6
P2860
Transdermal penetration enhancers: applications, limitations, and potential.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transdermal penetration enhancers: applications, limitations, and potential.
@ast
Transdermal penetration enhancers: applications, limitations, and potential.
@en
type
label
Transdermal penetration enhancers: applications, limitations, and potential.
@ast
Transdermal penetration enhancers: applications, limitations, and potential.
@en
prefLabel
Transdermal penetration enhancers: applications, limitations, and potential.
@ast
Transdermal penetration enhancers: applications, limitations, and potential.
@en
P356
P1476
Transdermal penetration enhancers: applications, limitations, and potential
@en
P2093
B C Finnin
P304
P356
10.1021/JS990154G
P407
P577
1999-10-01T00:00:00Z